Thermo Fisher Scientific Inc.TMONYSE
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank14
3Y CAGR-52.2%
5Y CAGR-51.0%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-52.2%/yr
vs -15.1%/yr prior
5Y CAGR
-51.0%/yr
Consistent
Acceleration
-37.1pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 0.50% |
| 2024 | 3.96% |
| 2023 | -9.11% |
| 2022 | 4.62% |
| 2021 | 19.05% |
| 2020 | 17.75% |
| 2019 | 3.72% |
| 2018 | 8.90% |
| 2017 | 17.65% |
| 2016 | 9.03% |